Netherlands· NL-e80a25bdce19

Oxaliplatine SUN 5 mg/ml, concentraat voor oplossing voor infusie

A oxaliplatin product containing oxaliplatine, registered in Netherlands by Sun Pharmaceutical Industries Europe B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L01XA03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about oxaliplatineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Oxaliplatin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01XA03 (oxaliplatin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search oxaliplatin products by name

Oxaliplatin · ATC L01XA03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxaliplatin costs, country by country.

Normalised to the WHO defined daily dose (11 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Oxaliplatin · price per daily dose (11 mg)

USD · FX 28 Sept 2026

CH Switzerland$24.21

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OXALIPLATINE
Manufacturer: Sun Pharmaceutical Industries Europe B.V.
Country: Netherlands (NL)
ATC code: L01XA03
ATC class: Oxaliplatin
Defined daily dose: 11 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
108042

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

740 interactions on record for oxaliplatin.

Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check oxaliplatin against other medicines How interaction checks work

Oxaliplatin · interactions on record

740 records

101 severe
453 moderate
1 minor
185 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxaliplatin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxaliplatin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Ebeoxal, Oxaliplatin Accord
Belgium · Eloxatin, Oxaliplatin Accord Healthcare
Bulgaria · Оксалиплатин Акорд, Оксалиплатин Булгермед
Cyprus · Oxaliplatin
Czechia · Oxaliplatin Accord, Oxaliplatin Agmed
Germany · Eloxatin, Medoxa
Denmark · Oxaliplatin Accord, Oxaliplatin Actavis
Estonia · Oxaliplatin Accord, Oxaliplatin Kabi
Spain · Oxaliplatino Accord, Oxaliplatino Aurovit
Finland · Oxaliplatin Accord
France · Dacplat, Eloxatine
United Kingdom (Northern Ireland) · Oxaliplatin Accord Healthcare, Oxaliplatin Amarox
Greece · Elatofen, Oxaliplatin Deltapharma
Croatia · Oksaliplatin Kalceks, Oxaliplatin Kabi
Hungary · Oxaliplatin Accord, Oxaliplatin Kabi
Ireland · Oxaliplatin Accord Healthcare Ireland, Oxaliplatin Fresenius Kabi Deutschland
Iceland · Oxaliplatin Actrevo, Oxaliplatin Teva
Italy · Oxaliplatino Accord, Oxaliplatino Aurobindo
Lithuania · Oxaliplatin Accord, Oxaliplatin Kabi
Luxembourg · Eloxatin, Oxaliplatine Fresenius Kabi
Latvia · Oxaliplatin Accord, Oxaliplatin Kabi
Malta · Oxaviatin
Norway · Oksaliplatin Sun, Oxaliplatin Fresenius Kabi
Poland · Oxaliplatin Ebewe, Oxaliplatin Eugia
Portugal · Oxaliplatina Accord, Oxaliplatina Aurovitas
Romania · Oxaliplatin Accord, Oxaliplatin Aqvida Gmbh
Sweden · Oxaliplatin Accord, Oxaliplatin Eugia
Slovenia · Oksaliplatin Kabi, Oksaliplatin Sandoz
Slovakia · Oxaliplatin Agmed, Oxaliplatin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c852f7ea-7ea5-4b90-b70e-f38a83063ac3
GET /v1/drugs/c852f7ea-7ea5-4b90-b70e-f38a83063ac3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h108042_smpc.pdf",
  "strength": null,
  "atc_label": "Oxaliplatin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg108042",
  "excipients": [
    "LACTOSE 1-WATER",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "OXALIPLATINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h108042.pdf",
  "authorised_at": "2011/08/01",
  "procedure_number": "DE/H/5677/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "108042",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about oxaliplatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console